| Postmenopausal atrophic vaginitis
Estrogel vs Osphena
Side-by-side clinical, coverage, and cost comparison for postmenopausal atrophic vaginitis.Deep comparison between: Estrogel vs Osphena with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsOsphena has a higher rate of injection site reactions vs Estrogel based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Osphena but not Estrogel, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Estrogel
Osphena
At A Glance
Topical
Daily
Estrogen
Oral
Daily
Estrogen receptor agonist/antagonist
Indications
- Menopausal syndrome
- Postmenopausal atrophic vaginitis
- Pain in female genitalia on intercourse
- Postmenopausal atrophic vaginitis
Dosing
Menopausal syndrome, Postmenopausal atrophic vaginitis EstroGel 0.06% 1.25 g (0.75 mg estradiol) once daily applied as a thin layer over the entire arm on the inside and outside from wrist to shoulder.
Pain in female genitalia on intercourse, Postmenopausal atrophic vaginitis One 60 mg tablet taken orally with food once daily.
Contraindications
- Abnormal genital bleeding of unknown etiology
- Current or history of breast cancer
- Current or history of estrogen-dependent neoplasia
- Active DVT, PE, or history of these conditions
- Active arterial thromboembolic disease (e.g., stroke or MI), or history of these conditions
- Known anaphylactic reaction, angioedema, or hypersensitivity to EstroGel or any excipient
- Hepatic impairment or disease
- Protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders
- Undiagnosed abnormal genital bleeding
- Estrogen-dependent neoplasia
- Active DVT, PE, or history of these conditions
- Active arterial thromboembolic disease (e.g., stroke, MI) or history of these conditions
- Hypersensitivity (e.g., angioedema, urticaria, rash, pruritus) to ospemifene or any ingredient
- Pregnancy or potential pregnancy
Adverse Reactions
Most common (>=5%) Breast pain, headache, flatulence
Serious Cardiovascular disorders, malignant neoplasms
Postmarketing Endometrial cancer, breast cancer, deep vein thrombosis, myocardial ischemia, phlebitis, nausea, alopecia, rash, retinal vein occlusion, meningioma, angioedema, hepatitis
Most common (>=1%) Hot flush, vaginal discharge, muscle spasms, hyperhidrosis
Serious Thromboembolic stroke, hemorrhagic stroke, DVT, malignant neoplasms
Postmarketing Endometrial hyperplasia, endometrial cancer, hypersensitivity, angioedema, headache, deep vein thrombosis, pulmonary embolism, rash, pruritus, urticaria
Pharmacology
Estradiol is the principal intracellular human estrogen, acting through binding to nuclear receptors in estrogen-responsive tissues; it modulates pituitary gonadotropin secretion via a negative feedback mechanism to reduce elevated LH and FSH levels seen in postmenopausal women.
Ospemifene is an estrogen receptor agonist/antagonist with tissue-selective effects, activating estrogenic pathways in some tissues (agonism) and blocking them in others (antagonism).
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Estrogel
- Covered on 5 commercial plans
- PA (4/12) · Step Therapy (0/12) · Qty limit (9/12)
Osphena
- Covered on 5 commercial plans
- PA (9/12) · Step Therapy (0/12) · Qty limit (9/12)
UnitedHealthcare
Estrogel
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (4/8)
Osphena
- Covered on 4 commercial plans
- PA (8/8) · Step Therapy (0/8) · Qty limit (8/8)
Humana
Estrogel
- Covered on 0 commercial plans
- PA (0/3) · Step Therapy (0/3) · Qty limit (0/3)
Osphena
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (0/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Estrogel.
No savings programs available for Osphena.
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
EstrogelView full Estrogel profile
OsphenaView full Osphena profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.